Skip to content

MOSAIC IMMUNOENGINEERING, INC.: 10-Q filed 2019-10-11

What MOSAIC IMMUNOENGINEERING, INC. reported in its quarterly report filed 2019-10-11 (fiscal Q1 2020): 23 published measures, 51 facts as tagged in accession 0001683168-19-003232.

This filing

Form
10-Q (quarterly report)
Filed
2019-10-11
Fiscal period
fiscal Q1 2020
Accession
0001683168-19-003232 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MOSAIC IMMUNOENGINEERING, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-08-311,618,184USD
At 2019-05-311,924,763USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-08-31264,891USD
At 2019-05-31228,212USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-08-311,353,293USD
At 2019-05-311,696,551USD
At 2018-08-312,282,096USD
At 2018-05-312,495,014USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-08-31738,660USD
At 2019-05-31787,086USD
At 2018-08-312,037,537USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-06-01 to 2019-08-31-343,258USD92
2018-06-01 to 2018-08-31-212,918USD92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-06-01 to 2019-08-31-320,022USD92
2018-06-01 to 2018-08-31-260,325USD92

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-06-01 to 2019-08-31250,000USD92
2018-06-01 to 2018-08-310USD92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-08-31-61,469,283USD
At 2019-05-31-61,126,025USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-06-01 to 2019-08-31398,548,318shares92
2018-06-01 to 2018-08-31398,548,318shares92

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2019-06-01 to 2019-08-31398,548,318shares92
2018-06-01 to 2018-08-31398,548,318shares92

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2019-06-01 to 2019-08-311,600USD92
2018-06-01 to 2018-08-311,600USD92

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-08-31692USD
At 2019-05-31814USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-08-311,501,787USD
At 2019-05-311,763,932USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-08-31264,891USD
At 2019-05-31228,212USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-08-3119,779USD
At 2019-05-318,868USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-06-01 to 2019-08-31303,037USD92
2018-06-01 to 2018-08-31203,481USD92

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2019-06-01 to 2019-08-31303,037USD92
2018-06-01 to 2018-08-31203,481USD92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-08-31401,392,948shares
At 2019-05-31401,392,948shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2019-08-31915,907USD
At 2019-05-31985,929USD
At 2018-08-312,059,124USD
At 2018-05-312,319,449USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2019-08-3177,444,062USD
At 2019-05-3177,444,062USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2019-08-31243,512USD
At 2019-05-31219,344USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-06-01 to 2019-08-31122USD92
2018-06-01 to 2018-08-31122USD92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2019-06-01 to 2019-08-31-38,621USD92
2018-06-01 to 2018-08-31-7,837USD92

Inspect the source

Entity
MOSAIC IMMUNOENGINEERING, INC. / CIK 0000836564
Captured
2026-09-19T15:08:56.564Z
SEC response SHA-256
20b7dbddee8b1aee5cb56cb4cf5c3c14c36ef1fafb538ec0211cfb2585ddf3fd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000836564.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))